JUBLPHARMAUpdated 4 Sept 2026, 2:49

Jubilant Pharmova Ltd

JUBLPHARMAUpdated 4 Sept 2026, 2:49

Market Cap

₹14,463Cr.

Current Price

₹908

High / Low

₹1,185/784

Stock P/E

458

ROE3.06%

ROCE1.80%

Book Value₹145

Face Value₹1.00

Dividend Yield0.55%

About

Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	37	47	57	54	51	49	0	66	85	90	325	33
Inventory Days	97	119	127	120	87	142	0	355	276	258	—	—
Days Payable	96	91	136	154	106	134	—	174	145	152	—	—
Cash Conversion Cycle	38	75	47	21	32	58	0	247	216	196	325	33
Working Capital Days	24	-19	22	6	-5	85	-13	126	93	88	254	-22
ROCE %	6%	7%	7%	14%	8%	10%	12%	4%	4%	3%	2%	2%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 4 September 2026 at 2:49

JUBILANT PHARMOVA LTD (JUBLPHARMA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding